| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 27808-223-01 | 27808-223 | HUMAN PRESCRIPTION DRUG | Paliperidone | paliperidone | TABLET, EXTENDED RELEASE | ORAL | 20211025 | N/A | ANDA | ANDA212807 | Tris Pharma Inc | PALIPERIDONE | 3 mg/1 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-223-01) |
| 27808-225-01 | 27808-225 | HUMAN PRESCRIPTION DRUG | Paliperidone | paliperidone | TABLET, EXTENDED RELEASE | ORAL | 20211025 | N/A | ANDA | ANDA212807 | Tris Pharma Inc | PALIPERIDONE | 9 mg/1 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-225-01) |
| 27808-224-01 | 27808-224 | HUMAN PRESCRIPTION DRUG | Paliperidone | paliperidone | TABLET, EXTENDED RELEASE | ORAL | 20211025 | N/A | ANDA | ANDA212807 | Tris Pharma Inc | PALIPERIDONE | 6 mg/1 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-224-01) |
| 27808-222-01 | 27808-222 | HUMAN PRESCRIPTION DRUG | Paliperidone | paliperidone | TABLET, EXTENDED RELEASE | ORAL | 20211025 | N/A | ANDA | ANDA212807 | Tris Pharma Inc | PALIPERIDONE | 1.5 mg/1 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (27808-222-01) |